TP53 and glioblastoma: Since the survival benefit of TMZ combined with VPA treatment was observed in newly diagnosed GBM patients with wild-type p53 (Figure 1D), we hypothesize that VPA may exert its pro-survival effect by enhancing the anticancer activity of TMZ dependent on the p53 gene status.